Revelation Partners Closes Revelation Healthcare Fund III at Hard Cap of $350 Million

 Revelation Partners, a dedicated secondary investor in healthcare, announced the first and final closing of its newest fund, Revelation Healthcare Fund III, at its hard cap of $350 million. The oversubscribed offering surpassed the initial target of $300 million and builds on the long-term investment success of the firm.

The firm, which now manages over $900 million of committed capital, specialises in providing shareholder liquidity, GP solutions, and growth capital for private healthcare companies and investors. The firm invests broadly across all healthcare sub-sectors, including medical devices, diagnostics, biotech, healthcare technology and healthcare services.

“With the tremendous amount of private capital that has flowed into the healthcare space over the last several years, our limited partners continue to see the attractive opportunity for Revelation Partners to provide liquidity in this illiquid market,” said Scott Halsted, founder and Managing Partner at Revelation Partners. In addition to the closing of the fund, the firm also announced three recent appointments: Fred Lee, promoted to Managing Director; Doug Fisher, appointed to Venture Partner; Suchira Sharma, appointed to Associate.

Revelation Partners provides flexible capital solutions to the healthcare ecosystem. These customized solutions provide liquidity, align shareholders and support the growth of privately-held healthcare companies. The firm’s long-term approach allows it to address the issues faced by a wide range of counterparties, including founders, company management teams, institutional investors (including general partners), and limited partners.

With decades of investing experience, deep sector expertise, an extensive industry network and over $900 million of committed capital, Revelation Partners is a trusted partner to healthcare companies, investors, founders, and funds.

Source: PR Newswire

Can’t stop reading? Read more